Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2020 Nov-Dec;14(6):1595-1602.
doi: 10.1016/j.dsx.2020.08.014. Epub 2020 Aug 20.

Burden of diabetes mellitus and its impact on COVID-19 patients: A meta-analysis of real-world evidence

Affiliations
Meta-Analysis

Burden of diabetes mellitus and its impact on COVID-19 patients: A meta-analysis of real-world evidence

Salman Hussain et al. Diabetes Metab Syndr. 2020 Nov-Dec.

Abstract

Background & aims: Coronavirus disease 2019 (COVID-19) spreads rapidly and within no time, it has been declared a pandemic by the World Health Organization. Evidence suggests diabetes to be a risk factor for the progression and poor prognosis of COVID-19. Therefore, we aimed to understand the pooled prevalence of diabetes in patients infected with COVID-19. We also aimed to compute the risk of mortality and ICU admissions in COVID-19 patients with and without diabetes.

Methods: A comprehensive literature search was performed in PubMed to identify the articles reporting the diabetes prevalence and risk of mortality or ICU admission in COVID-19 patients. The primary outcome was to compute the pooled prevalence of diabetes in COVID-19 patients. Secondary outcomes included risk of mortality and ICU admissions in COVID-19 patients with diabetes compared to patients without diabetes.

Results: This meta-analysis was based on a total of 23007 patients from 43 studies. The pooled prevalence of diabetes in patients infected with COVID-19 was found to be 15% (95% CI: 12%-18%), p = <0.0001. Mortality risk was found to be significantly higher in COVID-19 patients with diabetes as compared to COVID-19 patients without diabetes with a pooled risk ratio of 1.61 (95% CI: 1.16-2.25%), p = 0.005. Likewise, risk of ICU admission rate was significantly higher in COVID-19 patients with diabetes as compared to COVID-19 patients without diabetes with a pooled risk ratio of 1.88 (1.20%-2.93%), p = 0.006.

Conclusion: This meta-analysis found a high prevalence of diabetes and higher mortality and ICU admission risk in COVID-19 patients with diabetes.

Keywords: COVID-19; Diabetes; ICU admission; Meta-analysis; Mortality; Prevalence.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
PRISMA chart demonstrating study selection process.
Fig. 2
Fig. 2
Pooled prevalence of diabetes in COVID-19 patients.
Fig. 3
Fig. 3
Forest plot showing the pooled risk of mortality in COVID-19 patients with diabetes.
Fig. 4
Fig. 4
Forest plot showing the pooled risk of ICU admission in COVID-19 patients with diabetes.

References

    1. Zhu N., Zhang D., Wang W., Li X., Yang B., Song J. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020 - PMC - PubMed
    1. Drosten C., Günther S., Preiser W., Van Der Werf S., Brodt H.-R., Becker S. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med. 2003;348:1967–1976. - PubMed
    1. Coronavirus disease (COVID-19) situation report-168. https://www.who.int/docs/default-source/coronaviruse/situation-reports/2... Available at:
    1. Pan Y., Zhang D., Yang P., Poon L.L., Wang Q. Viral load of SARS-CoV-2 in clinical samples. Lancet Infect Dis. 2020;20:411–412. - PMC - PubMed
    1. Huang I., Lim M.A., Pranata R. Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia–A systematic review, meta-analysis, and meta-regression. Diabet Metabol Syndrome: Clin Res Rev. 2020 - PMC - PubMed

Publication types